SignatureFD’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.2K | Hold |
301
| – | – | ﹤0.01% | 1781 |
|
|
2025
Q1 | $31.6K | Hold |
301
| – | – | ﹤0.01% | 1815 |
|
|
2024
Q4 | $32.3K | Hold |
301
| – | – | ﹤0.01% | 1802 |
|
|
2024
Q3 | $30.1K | Hold |
301
| – | – | ﹤0.01% | 1838 |
|
|
2024
Q2 | $25.4K | Sell |
301
-12
| -4% | -$1.01K | ﹤0.01% | 1839 |
|
|
2024
Q1 | $22.9K | Hold |
313
| – | – | ﹤0.01% | 1933 |
|
|
2023
Q4 | $22.4K | Buy |
313
+208
| +198% | +$14.9K | ﹤0.01% | 1869 |
|
|
2023
Q3 | $6.29K | Hold |
105
| – | – | ﹤0.01% | 2404 |
|
|
2023
Q2 | $7.57K | Sell |
105
-37
| -26% | -$2.67K | ﹤0.01% | 2349 |
|
|
2023
Q1 | $10.4K | Hold |
142
| – | – | ﹤0.01% | 2188 |
|
|
2022
Q4 | $9.49K | Sell |
142
-78
| -35% | -$5.21K | ﹤0.01% | 2176 |
|
|
2022
Q3 | $12K | Buy |
220
+60
| +38% | +$3.27K | ﹤0.01% | 1983 |
|
|
2022
Q2 | $9K | Sell |
160
-26
| -14% | -$1.46K | ﹤0.01% | 2164 |
|
|
2022
Q1 | $13K | Buy |
186
+2
| +1% | +$140 | ﹤0.01% | 2036 |
|
|
2021
Q4 | $18K | Hold |
184
| – | – | ﹤0.01% | 1830 |
|
|
2021
Q3 | $16K | Sell |
184
-74
| -29% | -$6.44K | ﹤0.01% | 1857 |
|
|
2021
Q2 | $21K | Buy |
258
+32
| +14% | +$2.61K | ﹤0.01% | 1689 |
|
|
2021
Q1 | $21K | Sell |
226
-10
| -4% | -$929 | ﹤0.01% | 1550 |
|
|
2020
Q4 | $15K | Sell |
236
-86
| -27% | -$5.47K | ﹤0.01% | 1551 |
|
|
2020
Q3 | $19K | Buy |
322
+16
| +5% | +$944 | ﹤0.01% | 1395 |
|
|
2020
Q2 | $21K | Buy |
306
+269
| +727% | +$18.5K | ﹤0.01% | 1311 |
|
|
2020
Q1 | $2K | Buy |
+37
| New | +$2K | ﹤0.01% | 1952 |
|
|
2018
Q4 | – | Sell |
-1,202
| Closed | -$206K | – | 2010 |
|
|
2018
Q3 | $206K | Buy |
+1,202
| New | +$206K | 0.02% | 405 |
|